ArticleNanomaterials (Basel, Switzerland)2025
Exploring the Coating of Gold Nanoparticles with Lipids.
Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Applications of Functional Nanomaterials in Biomedical Science.Nanomaterials (Basel, Switzerland) · 2026Article
- A novel dual-action drug TJ94 facilitated by lipid nanocrystal formulations targeting neuroprotection and antithrombosis in ischemic stroke.Materials today. Bio · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
(1) Background: gold nanoparticles (AuNPs) are of particular interest in biomedical research because they possess unique optical properties. In particular, its localized surface plasmon resonance is widely used for photothermal therapy and for detecting molecular interactions at nanoparticle surfaces. To enhance circulation time and biocompatibility, nanoparticles are often coated to shield their hydrophobic character. (2) Methods: we explored the seed-growth method to coat AuNPs with phospholipids to improve colloidal stability. (3) Results: various charged phospholipids were tested, and particle size and zeta potential were characterized. The monodispersity of the coated nanoparticles strongly depends on the narrow size distribution of both gold nanoparticles seeds and lipid vesicles. Achieving stable coated AuNPs with zwitterionic lipids such as phosphatidylcholine was challenging, whereas coatings containing phosphatidylglycerol did not compromise nanoparticle stability. (4) Conclusions: coating AuNPs with phospholipids via the seed-growth method has potential but requires further optimization to improve reproducibility and achieve stable nanoparticles with near-neutral surface charge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.